Core Viewpoint - Kirby McInerney LLP is investigating potential claims against MediaAlpha, Inc. for possible violations of federal securities laws and unlawful business practices [1] Group 1: Allegations and Investigations - On June 24, 2024, Wolfpack Research published a report alleging that MediaAlpha was involved in consumer fraud, claiming that up to 78% of its health insurance lead-buying partners were engaged in scams or violating telemarketing laws [3] - Following the report, MediaAlpha's share price fell by approximately 6.85%, from $15.34 to $14.29 per share [3] - On November 4, 2024, the Federal Trade Commission (FTC) indicated it was prepared to file a complaint against MediaAlpha for misleading advertising and false affiliations with government entities, leading to a share price drop of about 27.73%, from $16.08 to $11.62 [4] Group 2: Settlement and Financial Impact - On August 6, 2025, MediaAlpha announced a settlement with the FTC for $45 million, related to claims that it misled consumers while collecting personal information for health insurance quotes [5] - The FTC's complaint highlighted that MediaAlpha sold approximately 119 million leads about consumers in 2024, indicating a significant volume of consumer data transactions [5]

Core Viewpoint - A class action securities lawsuit has been filed against Fiserv, Inc. alleging securities fraud that negatively impacted investors between July 24, 2024, and July 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Fiserv made false statements regarding its Clover platform, which was forced upon Payeezy merchants due to issues with the older platform [2]. - It is alleged that the revenue growth of Clover was artificially inflated by these conversions, masking a slowdown in acquiring new merchants [2]. - Following the conversions, many former Payeezy merchants reportedly switched to competitors due to Clover's high pricing and poor customer service, leading to a significant slowdown in Clover's GPV growth [2]. - The lawsuit asserts that Fiserv's positive statements about Clover's growth strategies and business prospects were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified period have until September 22, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Group 1 - Glancy Prongay & Murray LLP has initiated an investigation on behalf of Fluor Corporation investors regarding potential violations of federal securities laws [1] - The investigation is aimed at investors who have incurred losses on Fluor Corporation (NYSE: FLR) [1] - The announcement of the investigation was made on August 1, 2025 [1]

Core Viewpoint - Berger Montague PC is investigating potential securities fraud claims against Fiserv, Inc. following a class action lawsuit filed on behalf of investors who acquired Fiserv securities between July 24, 2024, and July 22, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that Fiserv and certain executives overstated the Company's growth by failing to disclose that its new payment platform, Clover, was experiencing increased revenue growth and gross payment volumes due to the forced transition of merchants from its legacy Payeezy platform [3]. - Investors became aware of the true financial situation of Fiserv after a series of disclosures, culminating on July 23, 2025, when the Company lowered its 2025 organic growth projections and confirmed decelerated growth in its Merchant segment [4]. Group 2: Investor Information - Investors who purchased or acquired Fiserv securities during the Class Period have until September 22, 2025, to seek appointment as a lead plaintiff representative of the class [2].

Group 1 - The Law Offices of Frank R. Cruz is investigating V.F. Corporation (VFC) for potential violations of federal securities laws [1] - The investigation is initiated on behalf of investors who may have lost money on V.F. Corporation [1] - V.F. Corporation released its fourth quarter and full year fiscal 2025 financial results on May 21, 2025 [1]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Lockheed Martin Corporation regarding a class action lawsuit due to allegations of misleading statements and lack of effective internal controls during a specified class period [1][2]. Allegations - The complaint alleges that Lockheed Martin lacked effective internal controls related to risk-adjusted contracts and profit booking rates [1]. - It is claimed that the company did not have adequate procedures for comprehensive reviews of program requirements, technical complexities, schedules, and risks [1]. - Lockheed Martin is accused of overstating its ability to meet contract commitments regarding cost, quality, and schedule [1]. - As a result of these issues, the company was likely to report significant losses [1]. - The positive statements made by the defendants about the company's business and prospects were deemed materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the lawsuit is from January 23, 2024, to July 21, 2025 [1]. - Shareholders are encouraged to register for the class action by September 26, 2025, to potentially be appointed as lead plaintiffs [2]. - There is no cost or obligation for shareholders to participate in the case [2].

Core Insights - DJS Law Group is investigating claims on behalf of investors of aTyr Pharma, Inc. for potential violations of securities laws [1] - The investigation centers on whether aTyr Pharma issued misleading statements or failed to disclose critical information to investors [2] - aTyr Pharma's experimental drug did not meet its primary goal in a late-stage study for pulmonary sarcoidosis, leading to a significant drop in share price by over 81% [2] Investigation Details - The investigation was prompted by a report from Reuters on September 15, 2025, regarding the failure of aTyr's drug in clinical trials [2] - The failure of the drug in the study is a key factor in the investigation, as it directly impacted investor confidence and share value [2] Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and asset managers [4] - The firm emphasizes the importance of protecting investor rights and maximizing returns through legal advocacy [4]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these actions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Core Viewpoint - Berger Montague PC is investigating potential securities fraud claims against CTO Realty Growth, Inc. following a class action lawsuit related to allegations of financial manipulation during a specified class period [1][3]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of investors who acquired CTO securities between February 18, 2021, and June 24, 2025 [1][2]. - The lawsuit alleges that a report by Wolfpack Research accused CTO of covering a $38 million dividend gap through significant share dilution and excluding necessary recurring capital expenditures from its Adjusted Funds From Operations [3]. Group 2: Stock Performance - Following the allegations made in the report, CTO's stock price fell nearly 6%, closing at $17.10 per share on June 25, 2025 [4]. Group 3: Company Background - CTO Realty Growth, Inc. is a real estate investment trust (REIT) headquartered in Winter Park, Florida [2].

Core Viewpoint - Fly-E Group, Inc. is facing a class action lawsuit due to significant financial losses and misleading statements made by the company regarding its business operations and prospects during the class period from July 15, 2025, to August 14, 2025 [3][5]. Financial Performance - On August 14, 2025, Fly-E reported a 32% year-over-year decline in net revenues, primarily attributed to decreased unit sales following multiple lithium-battery accidents involving its E-Bikes and E-Scooters [3]. - Following this announcement, Fly-E's stock price plummeted by $6.76, or 87.1%, closing at $1.00 per share on August 15, 2025, resulting in significant losses for investors [4]. Legal Proceedings - A class action lawsuit has been filed alleging that Fly-E's management made materially false and misleading statements about the company's brand reputation, cost reductions, and the risks associated with lithium batteries, which misled investors about the company's true financial health [5]. - Investors who purchased Fly-E securities during the class period are encouraged to file a lead plaintiff motion by the deadline of November 7, 2025, if they meet certain legal requirements [6].